Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_assertion type Assertion NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_head.
- NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_assertion description "[Detection rates of colorectal cancer using the tumor markers TFPI2 methylation, CEA and CA19-9, in the serum were 18%, 33%, and 17%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_provenance.
- NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_assertion evidence source_evidence_literature NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_provenance.
- NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_assertion SIO_000772 21820798 NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_provenance.
- NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_assertion wasDerivedFrom befree-20140225 NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_provenance.
- NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_assertion wasGeneratedBy ECO_0000203 NP525138.RAb4jrshLFon1o6KlvlTOL5Rb5DcxwRxbl3Mi5y4NsDFA130_provenance.